Generic medicine

Carbamazepine: Brands, Price & Uses in Bangladesh

Carbamazepine is an anticonvulsant and mood-stabilizing agent with established uses across several conditions and more.

Forms:Tablet

About Carbamazepine

Indications of Carbamazepine

Carbamazepine is an anticonvulsant and mood-stabilizing agent with established uses across several conditions, supported by different levels of clinical evidence:

Established / FDA-approved uses

  • Epilepsy — treatment of partial seizures with complex symptomatology (psychomotor, temporal lobe), generalized tonic-clonic seizures, and mixed seizure patterns. Carbamazepine is not effective for absence (petit mal) seizures and may worsen them.
  • Trigeminal neuralgia — treatment of pain associated with true trigeminal neuralgia.
  • Bipolar I disorder — treatment of acute manic and mixed episodes (extended-release formulations).

Guideline-supported / off-label uses

  • Neuropathic pain syndromes other than trigeminal neuralgia (e.g., glossopharyngeal neuralgia, diabetic neuropathy) — used off-label based on clinical guidelines and specialist experience.
  • Prophylaxis of bipolar disorder as a maintenance/mood-stabilizing agent, generally as an adjunct when first-line agents are unsuitable.

Use of Carbamazepine for any indication should be individualized and supervised by a physician.

Dosage & Administration of Carbamazepine

Epilepsy

PopulationInitial DoseTitrationUsual Maintenance / Maximum
Adults and children >12 years200 mg twice dailyIncrease by up to 200 mg/day at weekly intervals, divided dosesUsual maintenance 800–1200 mg/day; maximum generally 1000 mg/day (12–15 years) to 1200 mg/day (>15 years), occasionally up to 1600–2000 mg/day under specialist supervision
Children 6–12 years100 mg twice dailyIncrease by up to 100 mg/day at weekly intervals, divided dosesMaximum 1000 mg/day
Children under 6 years10–20 mg/kg/day in 2–3 divided dosesIncrease gradually as needed and toleratedIndividualized; per specialist guidance

Trigeminal Neuralgia

Initial: 100 mg twice daily on day 1, increased gradually by up to 200 mg/day as needed for pain relief. Usual maintenance dose is 400–800 mg/day; maximum 1200 mg/day. Attempts to reduce to the minimum effective dose should be made at intervals of 3 months.

Bipolar I Disorder (acute manic/mixed episodes)

Extended-release formulation: initial 200 mg twice daily, adjusted in increments of up to 200 mg/day; usual target dose range 400–1600 mg/day in divided doses, guided by clinical response and tolerability.

Administration

Take with food to minimize gastrointestinal upset. Extended-release tablets/capsules must be swallowed whole and not crushed or chewed. Chewable tablets should be chewed thoroughly. Shake oral suspension well before use. Do not switch abruptly between formulations without medical guidance, as bioavailability differs.

Renal/Hepatic Impairment

Use with caution in hepatic impairment; dose reduction or avoidance may be needed in significant hepatic disease. No formal dosage adjustment is established for renal impairment, but caution is advised, and levels should be monitored.

Side Effects of Carbamazepine

Serious warnings (see Precautions and Warnings for full detail): severe dermatologic reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) and blood dyscrasias (aplastic anemia, agranulocytosis).

Common side effects

  • Dizziness, drowsiness, unsteadiness (ataxia)
  • Nausea, vomiting
  • Double or blurred vision (diplopia)
  • Headache
  • Mild skin rash

Less common but serious side effects

  • Hyponatremia (due to SIADH-like effect)
  • Blood dyscrasias — leukopenia, thrombocytopenia, aplastic anemia, agranulocytosis (see Precautions)
  • Hepatotoxicity — abnormal liver function, jaundice, hepatitis
  • Cardiac conduction disturbances (AV block, arrhythmias)
  • Severe skin reactions — SJS/TEN, exfoliative dermatitis, drug reaction with eosinophilia and systemic symptoms (DRESS) (see Precautions)
  • Pancreatitis

Contraindications of Carbamazepine

Carbamazepine is contraindicated in patients with:

  • Known hypersensitivity to Carbamazepine or structurally related tricyclic compounds (e.g., tricyclic antidepressants).
  • History of bone marrow suppression/depression.
  • Concurrent use of, or use within the preceding 14 days of, monoamine oxidase inhibitors (MAOIs).
  • Concurrent use with nefazodone.
  • Known presence of the HLA-B*1502 allele in patients of at-risk ancestry (e.g., Han Chinese, Thai, and other South/East Asian populations), given the markedly increased risk of Stevens-Johnson syndrome/toxic epidermal necrolysis; genetic testing is recommended before initiating therapy in these populations.

Frequently Asked Questions about Carbamazepine

What is Carbamazepine used for?

Carbamazepine is mainly used to treat epilepsy (partial seizures, generalized tonic-clonic seizures, and mixed seizure patterns), trigeminal neuralgia (a nerve pain condition), and acute manic or mixed episodes of bipolar I disorder.

Can I stop taking Carbamazepine suddenly if I feel better?

No. Stopping Carbamazepine abruptly can trigger seizures or worsen your underlying condition. Always consult your physician before reducing the dose or stopping treatment; discontinuation should be gradual.

Are there any serious risks I should know about before starting Carbamazepine?

Yes. Carbamazepine can rarely cause serious skin reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) and blood disorders (aplastic anemia, agranulocytosis). The skin reaction risk is much higher in people with a genetic marker called HLA-B*1502, which is more common in people of Han Chinese, Thai, and some other Asian ancestries — genetic testing is recommended in these populations before starting therapy. Report any fever, mouth sores, rash, unusual bruising, or signs of infection to your doctor immediately.

Can Carbamazepine be used during pregnancy?

Carbamazepine can cause birth defects, including neural tube defects, and should be used in pregnancy only if clearly needed and the benefit outweighs the risk, generally as monotherapy at the lowest effective dose. Folic acid supplementation is recommended. Do not stop Carbamazepine during pregnancy without consulting your physician, as uncontrolled seizures also carry risks.

Does Carbamazepine interact with other medicines, including birth control pills?

Yes. Carbamazepine induces liver enzymes and can reduce the effectiveness of many drugs, including hormonal contraceptives, warfarin, and some other anticonvulsants. It is contraindicated with MAOIs and nefazodone. Always tell your doctor about all medications you are taking, including herbal products and grapefruit juice consumption, which can raise Carbamazepine levels.

What should I do if I miss a dose or take too much Carbamazepine?

If you miss a dose, take it as soon as you remember unless it is close to the next dose — do not double up. If you or someone else has taken too much Carbamazepine, seek immediate medical attention or contact emergency services/poison control, as overdose can be life-threatening.

Disclaimer

The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.

DoctorBlogArticles